| Cat. No. |
Product Name |
Information |
| PC-70016 |
AH-23848 calcium salt
TP1/EP4 antagonist
|
AH-23848 calcium salt is a dual antagonist of TP1 and EP4 receptors that inhibit TXA2-induced platelet aggregation with IC50 of 0.26 uM. |
| PC-42574 |
AH6809
PGD2 antagonist
|
AH6809 is a xanthone derivative that fuctions as an EP and DP receptor antagonist with Ki of 1217, 1150, 1597, and 1415 nM for the cloned human EP1, EP2, EP3-III, and DP receptor respectively. |
| PC-45075 |
Fevipiprant
CRTH2 inhibitor
|
Fevipiprant (NVP-QAW039, QAW-039) is a potent, selective, slowly dissociating CRTh2 antagonist with Kd of 1.14 nM. |
| PC-42700 |
CJ-042794
EP4 antagonist
|
CJ-042794 (CJ-42794) is a potent, selective prostaglandin E receptor subtype 4 (EP4) antagonist with pKi of 8.5. |
| PC-42699 |
MF498
EP4 antagonist
|
MF498 is a selective prostaglandin E receptor subtype 4 (EP4) antagonist with Ki of 0.74 nM. |
| PC-46004 |
MRE-269
IP receptor inhibitor
|
MRE-269 (ACT-333679) is a potent, selective IP receptor (prostaglandin I2 receptor) agonist with Ki of 20 nM. |
| PC-45896 |
ONO-AE3-208
EP4 antagonist
|
ONO-AE3-208 (AE3-208) is a potent, selective EP4 receptor antagonist with Ki of 1.3 nM. |
| PC-45118 |
Terutroban
Prostanoid TP receptor antagonist
|
Terutroban (S-18886) is a potent, selective antagonist of the thromboxane receptor (Prostanoid TP receptor) that blocks thromboxane induced platelet aggregation and vasoconstriction. |
| PC-42387 |
PGD2-IN-1
PGD2 antagonist
|
PGD2-IN-1 is a potent prostaglandin D2 receptor (PGD2, DP) receptor antagonist with IC50 of 0.3 nM. |
| PC-45826 |
Laropiprant
DP1 antagonist
|
Laropiprant (MK-0524) is a potent and selective prostaglandin D2 (PGD2) receptor (DP1) antagonist with Ki of 0.57 nM. |
| PC-45103 |
GW627368
EP4 antagonist
|
GW627368 is a potent and selective competitive antagonist of prostanoid EP4 receptor with pKi of 7.0. |
| PC-45111 |
TG6-10-1
EP2 antagonist
|
TG6-10-1 is a potent and selective antagonist of prostaglandin E2 receptor subtype EP2 with Kb of 17.8 nM. |
